Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 8Unknown 4Withdrawn 2Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 369Neoplasms 253Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 192Lung Neoplasms 140Colorectal Neoplasms 137Neoplasm Metastasis 132Pancreatic Neoplasms 131Leukemia, Myeloid, Acute 126Multiple Myeloma 122Lymphoma 114Carcinoma, Hepatocellular 111Ovarian Neoplasms 98Melanoma 97Recurrence 93Leukemia 88Head and Neck Neoplasms 88Leukemia, Lymphocytic, Chronic, B-Cell 86Brain Neoplasms 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Glioblastoma 77Lymphoma, Non-Hodgkin 73Squamous Cell Carcinoma of Head and Neck 71Lymphoma, Follicular 70Lymphoma, Large B-Cell, Diffuse 66Colonic Neoplasms 66Carcinoma, Renal Cell 61Hematologic Neoplasms 59Sarcoma 55Glioma 53

Interventions

Water 1Thyroxine 1Tea 1Milk 1Coffee 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Hypothyroidism × Clear all
NCT02548715 2022-07-13

LSHT

University of Alberta

Phase 2/3 Withdrawn
Head & Neck

Hypothyroidism, Neoplasms, Postoperative Complications

NCT01707056 2021-02-17

The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma

Medstar Health Research Institute

Phase NA Withdrawn
Head & Neck

Hypothyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡